5,5-Diphenylhydantoin sodium salt - CP

CAS : 630-93-3

Ref. 3D-FD175285

Informations sur le produit

• Nom: 5,5-Diphenylhydantoin sodium salt - CP
• Synonymes: Phenytoin Sodium, 5,5-Diphenylhydatoin sodium salt, 4-Ethyloctanoic acid methyl ester, 2,4-Imidazolidinedione, 5,5-Diphenyl-, Sodium Salt (1:1), 2,4-Imidazolidinedione, 5,5-diphenyl-, monosodium salt, 5,5-Diphenyl-2,4-imidazolidinedione sodium salt, 5,5-Diphenylhydantoin sodium, Aleviatin sodium, Antisacer, Danten, Difenin, Difhydan, Dilantin, Diphantoine, Diphenin, Diphenine, Diphenylan sodium, Diphenylhydantoin sodium, Ditoin, Enkefal, Epanutin, Epelin, Epilan D, Epsolin, Eptoin, Fenitoin sodium, Fenitoina Sodica, Hydantin, Hydantoin, 5,5-diphenyl-, sodium salt, Hydantoinal, Minetoin, M-toin, Phenyloin, Phenytoin soluble, Phenytoine sodique, Phenytoinnatrium, Prompt, Sodium 5,5-diphenyl-2,4-imidazolidinedione, Sodium 5,5-diphenylhydantoin, Sodium diphenylhydantoin, Sodium diphenylhydantoinate, Sodium phenytoin, Solantyl, Soluble Phenytoin, Tacosal
• CAS: 630-93-3

Description

Diphenylhydantoin is an anticonvulsant that inhibits the sodium channels in nerve cells, which are responsible for the propagation of nerve impulses. It is used to treat epilepsy and other seizure disorders. Diphenylhydantoin has been shown to reduce antibody responses in mice and humans, which may be due to its ability to inhibit lymphocyte transformation. Diphenylhydantoin also has cardiac effects and can lead to heart failure or arrhythmia. It has been shown that diphenylhydantoin may be a risk factor for cervical cancer and cardiac disease in fetal bovine serum-derived monoclonal antibodies. Some patients experience depression as a side effect of this drug, which may be due to its ability to inhibit monoamine oxidase B (MAO-B).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 274.25 g/mol
• Formule: C₁₅H₁₁N₂NaO₂
• Degré de pureté: Min. 95%